Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Randall D. Seifert"'
Autor:
Meena N. Murugappan, Bellinda L. King-Kallimanis, Vishal Bhatnagar, Bindu Kanapuru, Joel F. Farley, Randall D. Seifert, David D. Stenehjem, Ting-Yu Chen, Erica G. Horodniceanu, Paul G. Kluetz
Publikováno v:
Quality of Life Research.
Autor:
Joel F. Farley, David D. Stenehjem, Susan M. Wolf, Josiah D Allen, Constantin F. Aliferis, Erin J McGonagle, Steven G. Johnson, Robert J. Straka, Jason Wachtl, Catherine A. McCarty, Christine Kroger, Pinar Karaca Mandic, Pamala A. Pawloski, Allyson Schlichte, Julie England, Susie E Long, Heather Zierhut, Pamala A. Jacobson, Wayne T. Nicholson, Eric T. Matey, Sisi Ma, Stephen W. Schondelmeyer, Tiana Luczak, Suzette J. Bielinski, Pawel Mroz, Jacob T. Brown, Jeffrey R. Bishop, Jyothsna Giri, David Gregornik, Stephen C. Waring, Natasha Petry, R. Stephanie Huang, Ann M. Moyer, Marilyn K. Speedie, Randall D. Seifert, Brian G Van Ness
Publikováno v:
Pharmacogenomics
Several healthcare organizations across Minnesota have developed formal pharmacogenomic (PGx) clinical programs to increase drug safety and effectiveness. Healthcare professional and student education is strong and there are multiple opportunities in
Publikováno v:
Journal of the American Pharmacists Association. 60:S54-S63
To describe and compare the delivery of medication therapy management (MTM) between Medicare beneficiaries with and without mental health conditions.Nationally representative cross-sectional study that used a 20% random sample of 2014 Medicare Parts
Autor:
Randall D. Seifert, Robert Buckner Jones, Laura Schwartzwald, Meena N. Murugappan, ShuYing Ng, Kevin Edwards, Amy L. Pittenger
Publikováno v:
INNOVATIONS in Pharmacy, Vol 10, Iss 2 (2019)
Innovations in Pharmacy
Innovations in Pharmacy
Purpose: The purpose of this article is to describe how an innovative partnership between a rural community mental health center, community independent pharmacy and College of Pharmacy and integration of a mental health pharmacist lead to identificat
Publikováno v:
Journal of the American Pharmacists Association. 60:571-579.e1
To describe and compare the delivery of medication therapy management (MTM) between Medicare beneficiaries with and without mental health conditions.Nationally representative cross-sectional study that used a 20% random sample of 2014 Medicare Parts
Autor:
Randall D. Seifert, Meg M. Little, Susan Nokleby, Jennifer Koziol Wozniak, Erika Yoney, Cynthia Van Kirk, Sara Eischens, Mary Jo Martin, Laura C. Palombi, Ya Feng Wen, Jayme van Risseghem
Publikováno v:
Journal of the American Pharmacists Association. 58:67-72.e1
Background Pharmacist participation in school medication management (MM) is minimal. School nurses are responsible for increasingly complex medication administration and management in schools. Objectives The purpose of this study was to 1) assess the
Publikováno v:
Journal of Managed Care Pharmacy. 14:1-30
BACKGROUND: Acute coronary syndrome (ACS) is caused by reduced perfusion of the myocardium and characterized by chest pain. The primary goals of treatment for ACS are to restore blood flow through occluded coronary arteries and prevent recurrent coro
Autor:
Randall D. Seifert
Publikováno v:
Journal of Managed Care Pharmacy. 14:24-27
BACKGROUND: Acute coronary syndrome (ACS) and venous thrombo embolism (VTE) are costly conditions, largely due to the high initial cost of treatment, patient nonadherence to prescribed antiplatelet therapy, avoidable rehospitalization in patients w
Autor:
Randall D. Seifert, Neal R. Cutler, Margo M. Schleman, Thomas S. Wardle, Eric P. Brass, Aaron Barchowsky, John J. Sramek, Danny R. Howard, Olo J. Szylleyko
Publikováno v:
Clinical Pharmacology & Therapeutics. 58:54-61
Objective To determine the pharmacokinetics, pharmacodynamics and safety of the acetylcholinesterase inhibitor zifrosilone in healthy male volunteers. Methods Pharmacokinetics, pharmacodynamics, and tolerance of zifrosilone were studied in a double-b
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 19:85-91
1. In this double-blind, placebo-controlled phase I study of the safety/tolerance of two doses of xanomeline tartrate (100 mg and 115 mg tid) given to 12 AD patients, the authors measured serum amylase, fractionated into pancreatic and salivary isoen